ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia
Links shared publicly online about this topic.
- 1,075total visits
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia
Enobia Pharma announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After
View full resource at medicalnewstoday.com
Tags: Bone, Pharma, Children's Health
Most Recently Shared on June 23, 2010 at 3:05 am By:
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia http://mnt.to/3Fb3 #clinicaltrials
Also Shared By:
Advertisement
MNT Bones/Orthopedic
@mnt_bones
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia http://mnt.to/3Fb3 #bones #orthopedics
1 year ago...